MedTrace Logo

pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study

NCT07515261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-04-07

No results posted yet for this study

Summary

This study will evaluate the feasibility and preliminary efficacy of pBFS-guided TMS treatment at DMPFC in autism spectrum disorder comorbid with language delay.

Conditions

  • Autism Spectrum Disorder With Language Delay

Interventions

DEVICE

active iTBS

Each participant will receive 1800 pulse active iTBS (100% RMT) in each session, 3 sessions per day, 5 days per week for 8 weeks.

Sponsors & Collaborators

  • China Rehabilitation Research Center

    collaborator OTHER_GOV

  • Henan Provincial People's Hospital

    collaborator OTHER

  • Changping Laboratory

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-10
Primary Completion
2024-02-27
Completion
2024-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07515261 on ClinicalTrials.gov